Compare SHASUN PHARMA with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SANOFI INDIA SHASUN PHARMA/
SANOFI INDIA
 
P/E (TTM) x 123.9 41.3 300.0% View Chart
P/BV x 8.5 7.2 117.9% View Chart
Dividend Yield % 0.2 1.2 19.4%  

Financials

 SHASUN PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SANOFI INDIA
Dec-18
SHASUN PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs946,840 1.4%   
Low Rs464,630 1.0%   
Sales per share (Unadj.) Rs214.21,203.1 17.8%  
Earnings per share (Unadj.) Rs5.3165.3 3.2%  
Cash flow per share (Unadj.) Rs15.8209.9 7.5%  
Dividends per share (Unadj.) Rs1.0084.00 1.2%  
Dividend yield (eoy) %1.41.5 97.7%  
Book value per share (Unadj.) Rs53.3963.6 5.5%  
Shares outstanding (eoy) m56.6223.03 245.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.8 6.8%   
Avg P/E ratio x13.134.7 37.7%  
P/CF ratio (eoy) x4.427.3 16.2%  
Price / Book Value ratio x1.36.0 22.0%  
Dividend payout %18.750.8 36.9%   
Avg Mkt Cap Rs m3,958132,078 3.0%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m2,1644,068 53.2%   
Avg. sales/employee Rs ThNM8,393.8-  
Avg. wages/employee Rs ThNM1,232.4-  
Avg. net profit/employee Rs ThNM1,153.0-  
INCOME DATA
Net Sales Rs m12,12727,708 43.8%  
Other income Rs m229897 25.6%   
Total revenues Rs m12,35628,605 43.2%   
Gross profit Rs m1,0096,235 16.2%  
Depreciation Rs m5941,027 57.8%   
Interest Rs m4157 5,930.0%   
Profit before tax Rs m2306,098 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-732,292 -3.2%   
Profit after tax Rs m3023,806 7.9%  
Gross profit margin %8.322.5 37.0%  
Effective tax rate %-31.737.6 -84.2%   
Net profit margin %2.513.7 18.1%  
BALANCE SHEET DATA
Current assets Rs m6,88415,922 43.2%   
Current liabilities Rs m8,4566,235 135.6%   
Net working cap to sales %-13.035.0 -37.1%  
Current ratio x0.82.6 31.9%  
Inventory Days Days6264 96.8%  
Debtors Days Days10821 515.4%  
Net fixed assets Rs m4,9707,539 65.9%   
Share capital Rs m113230 49.3%   
"Free" reserves Rs m2,87521,962 13.1%   
Net worth Rs m3,02022,192 13.6%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34729,839 44.7%  
Interest coverage x1.6872.1 0.2%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.90.9 97.8%   
Return on assets %5.412.8 42.1%  
Return on equity %10.017.2 58.3%  
Return on capital %13.327.5 48.4%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8437,587 77.0%   
Fx outflow Rs m2,1737,145 30.4%   
Net fx Rs m3,669442 830.2%   
CASH FLOW
From Operations Rs m3983,739 10.6%  
From Investments Rs m-1,635-731 223.7%  
From Financial Activity Rs m1,309-1,972 -66.4%  
Net Cashflow Rs m711,036 6.9%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.6 14.4 25.0%  
FIIs % 17.6 14.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 10.5 377.1%  
Shareholders   20,750 15,184 136.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS